Lung Cancer
B8011011
A Phase 1b/2 Open Label Umbrella Study of Sasanlimab Combined With Anti-Cancer Therapies Targeting Multiple Molecular Mechanisms in Participants With Non-Small Cell Lung Cancer (NSCLC).
Trial overview
Topic
Carcinoma, non-small-cell lung
Eligibility criteria
- Non-Small Cell Lung Cancer, please enquire for further details.
Study details
While on treatment there will be regular blood tests and scans to monitor progress. At completion of treatment the study will continue to follow your progress.
Further information
For more information regarding this clinical trial click here.
Location